Skip to main content

Right to FDA-Approved Medicines Act (H.R. 4525)

Referred to Committee
Introduced 7/17/2025•119th Congress•House

Latest Action

Referred to the House Committee on Energy and Commerce.

7/17/2025 • House

Summary

Right to FDA-Approved Medicines Act

This bill sets out statutory protections for an individual's right to access and a health care provider's right to provide medicines (i.e., drugs and biological products) approved by the Food and Drug Administration (FDA).

Generally, the bill prohibits measures that single out and impede access to FDA-approved medicines and related information. However, a party may defend against a claim that a measure violates the bill's prohibitions by demonstrating, through clear and convincing evidence, that the measure significantly advances access to FDA-approved medicines and such access cannot be advanced through less restrictive means. The bill also specifies that the prohibition preempts inconsistent state and local laws and applies in spite of other federal laws, including the Religious Freedom Restoration Act of 1993.

The Department of Justice, individuals, or health care providers may bring a lawsuit to enforce this bill, and states are not immune from suits for violations.

Introduced in House • 7/17/2025

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (30)

Party Breakdown

30
Democrats
0
Republicans
0
Independents

Sponsor

R[
Rep. Ross, Deborah K. [D-NC-2]

Democrat • NC-2

Sponsored 7/17/2025

Cosponsors (29)

R[
Rep. Schrier, Kim [D-WA-8]

D-WA-8

Joined 7/17/2025

R[
Rep. Castor, Kathy [D-FL-14]

D-FL-14

Joined 7/17/2025

R[
Rep. Trahan, Lori [D-MA-3]

D-MA-3

Joined 7/17/2025

R[
Rep. Fletcher, Lizzie [D-TX-7]

D-TX-7

Joined 7/17/2025

R[
R[
Rep. Williams, Nikema [D-GA-5]

D-GA-5

Joined 7/29/2025

Bill Journey

Originated in the House

Introduced

July 17, 2025

Referred to the House Committee on Energy and Commerce.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House7/17/2025

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors29

Sources and method

· Record updated Oct 28, 2026
  • Congress.govLibrary of Congress
    Status, actions, sponsors, cosponsors, committees and text
    Record updated Oct 28, 2026 · Loaded Oct 28, 2026, 5:21 PM ET
  • CRS bill summaryCongressional Research Service, via Congress.gov
    Official summary
    Summary of the “Introduced in House” version, Jul 17, 2025 · Loaded Oct 28, 2026, 5:21 PM ET
  • USAspending.govU.S. Department of the Treasury
    Related Federal Spending section
  • FEC filingsFederal Election Commission
    Funding & Lobbying section
  • Lobbying disclosures (LDA)Secretary of the Senate and Clerk of the House
    Funding & Lobbying section

All sources: Public domain (17 U.S.C. § 105) · Method: Data sources → · Campaign finance →

AI-written text on this page is labeled where it appears. It is written from the sources above and is not a source itself. How we analyze data →

Dates shown where the source reports one. “Loaded” is when CIV.IQ last fetched the record.